BELLEZZA, Guido
 Distribuzione geografica
Continente #
NA - Nord America 7.109
EU - Europa 5.300
AS - Asia 4.707
SA - Sud America 831
AF - Africa 140
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 18.115
Nazione #
US - Stati Uniti d'America 6.901
SG - Singapore 2.101
IT - Italia 1.088
IE - Irlanda 827
UA - Ucraina 714
CN - Cina 680
BR - Brasile 639
HK - Hong Kong 632
RU - Federazione Russa 628
VN - Vietnam 458
SE - Svezia 448
DE - Germania 379
FR - Francia 323
FI - Finlandia 264
KR - Corea 232
GB - Regno Unito 210
CA - Canada 120
IN - India 111
BD - Bangladesh 102
RO - Romania 86
AR - Argentina 69
TR - Turchia 69
PL - Polonia 59
MX - Messico 50
JP - Giappone 44
IQ - Iraq 42
NL - Olanda 42
PK - Pakistan 40
BE - Belgio 39
AT - Austria 38
EC - Ecuador 31
ID - Indonesia 31
ZA - Sudafrica 31
ES - Italia 30
CH - Svizzera 29
UZ - Uzbekistan 26
MA - Marocco 23
EG - Egitto 20
VE - Venezuela 20
CO - Colombia 18
PH - Filippine 16
PT - Portogallo 16
PY - Paraguay 16
AU - Australia 15
BO - Bolivia 14
CZ - Repubblica Ceca 14
GR - Grecia 14
LB - Libano 14
KE - Kenya 12
MY - Malesia 12
SA - Arabia Saudita 12
TN - Tunisia 12
CL - Cile 11
JO - Giordania 10
LT - Lituania 10
IL - Israele 9
AL - Albania 8
NP - Nepal 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
CR - Costa Rica 7
JM - Giamaica 7
TH - Thailandia 7
DZ - Algeria 6
EU - Europa 6
OM - Oman 6
PE - Perù 6
AZ - Azerbaigian 5
CI - Costa d'Avorio 5
KG - Kirghizistan 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AO - Angola 4
ET - Etiopia 4
GT - Guatemala 4
KH - Cambogia 4
MD - Moldavia 4
PS - Palestinian Territory 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
HN - Honduras 3
LK - Sri Lanka 3
MT - Malta 3
RS - Serbia 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BN - Brunei Darussalam 2
BW - Botswana 2
HU - Ungheria 2
KZ - Kazakistan 2
LY - Libia 2
ML - Mali 2
MN - Mongolia 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SR - Suriname 2
Totale 18.082
Città #
Singapore 1.463
Chandler 1.003
Dublin 826
Hong Kong 628
San Jose 607
Ashburn 439
Jacksonville 387
San Mateo 367
Boardman 329
Perugia 284
Santa Clara 263
Seoul 232
Moscow 229
Ann Arbor 189
Medford 184
Princeton 183
Beijing 171
Lauterbourg 169
Altamura 159
Council Bluffs 158
Dong Ket 156
Wilmington 147
Munich 135
Lawrence 120
The Dalles 112
Los Angeles 108
Andover 107
Ho Chi Minh City 102
New York 99
Piscataway 82
Bucharest 79
Helsinki 77
São Paulo 68
Hanoi 64
Saint Petersburg 53
Ottawa 50
Rome 47
Frankfurt am Main 44
Shanghai 44
Tokyo 43
Orem 42
Woodbridge 40
Des Moines 39
Brussels 37
Milan 37
Redmond 36
Norwalk 35
Dallas 30
San Paolo di Civitate 30
Turku 30
London 29
Montreal 29
Stockholm 28
Houston 26
Chennai 25
Nuremberg 25
Warsaw 24
Chicago 23
Redwood City 23
Philadelphia 21
Atlanta 20
Phoenix 20
San Francisco 20
Auburn Hills 19
Izmir 19
Amsterdam 18
Brooklyn 18
Poplar 18
Falkenstein 17
Rio de Janeiro 17
Haiphong 16
Kraków 16
Mexico City 16
Baghdad 15
Denver 15
Johannesburg 15
Columbus 14
Curitiba 14
Tashkent 14
Bologna 13
Guangzhou 13
Lahore 13
Mumbai 13
Naples 13
Quito 13
Boston 12
Brasília 12
Da Nang 12
Hefei 12
Istanbul 12
Toronto 12
Falls Church 11
Lappeenranta 11
Amman 10
Ankara 10
Bexley 10
Caracas 10
Nairobi 10
Salvador 10
Vienna 10
Totale 11.179
Nome #
Granuloma piogenico: revisione della letteratura e presentazione di un caso 262
Angiosarcoma primitivo del surrene 239
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 193
Aspirato con ago sottile dei noduli tiroidei: striscio convenzionale vs preparato in strato sottile. 173
Condromatosi sinoviale primitiva dei tessuti molli. 171
Espressione della sialoproteina ossea, dell’osteopontina e dell’osteonectina nel carcinoma prostatico 168
Garcinoic Acid Is a Natural and Selective Agonist of Pregnane X Receptor 156
Primary mucinous carcinoma of the skin 140
Glyoxalase 2 Is Involved in Human Prostate Cancer Progression as Part of a Mechanism Driven By PTEN/PI3K/AKT/mTOR Signaling With Involvement of PKM2 and ERα 139
Nuovi metodi di rilevazione delle micrometastasi linfonodali. XXIII Congresso Nazionale di Chirurgia Oncologica 139
Nested Type Bladder Cancer: A Tricky Entity A Report of Two Cases 134
p53 overexpression predicts the resistance to chemotherapy in advanced non small cell lung cancer (NSCLC)". 133
Valutazione anatomo-patologica dell’unità feto-placentare nella morte prenatale. 133
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in a resected non-small cell lung cancer series 132
Prognostic Role of Erbb Family Receptors, Myc and Mitogen-activated Protein Kinase (mapk) In Patients With Early-stage Non Small-cell Lung Cancer 129
Leiomyoma of the breast: case report and review of the literature. 129
Appendiceal mucocele. A case report and literature review 129
Gene identification for risk of relapse in stage I lung adenocarcinoma patients: A combined methodology of gene expression profiling and computational gene network analysis 129
The correlation of protein peroxidation with morphological changes in experimental oestradiol-induced carcinogenesis 128
Apocrine intraductal carcinomas arising in two fibroadenomas: report of an unusual case. 128
Ossificazione eterotopica e patologia tiroidea: descrizione di 6 casi e revisione della letteratura 126
6th National Conress of Medical Oncology 124
Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non small cell lung cancer (NSCLC) 123
Significato prognostico dell’espressione immunoistochimica di Insulin like growth facor receptor 1 (IGFR-1) ed epidermal growth factor receptor (EGFR) nei carcinomi non a piccole cellule del polmone (NSCLC). 123
CD10 is frequently expressed in classical seminomas. 123
Biological Prognostic Factors for early stage completely resected NSCLC 122
P-126 * PROGNOSTIC SIGNIFICANCE OF MYC AND HUMAN TELOMERASE GENE AMPLIFICATION IN SURGICALLY TREATED EARLY STAGE NON-SMALL CELL LUNG CANCER 121
Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient with High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib 120
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer 118
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 118
Immunohistochemical expression of IMP3 in non small cell lung cancer. 117
Effectiveness and predictability of pleurodesis with the Tachosil® surgical patch compared with talc poudrage: An experimental study 117
Classification Model to Estimate MIB-1 (Ki 67) Proliferation Index in NSCLC Patients Evaluated With 18F-FDG-PET/CT 116
Espressione di MKP-1 nei noduli iperplastici, adenomi e carcinomi papillari della tiroide. 115
1° Simposio Nazionale di Citopatologia "Dallo screening alla citologia diagnostica" 115
Predictors of resistance to chemotherapy and prognosis in advanced non-small cell lung cancer. 114
Espressione di EGFR e timidilato sintetasi nel carcinoma rettale: correlazioni anatomo-cliniche e significato prognostico - IV Congresso Nazionale di Anatomia Patologica 114
Coexpression of HER-2/neu and p53 in breast cancer identifies a subset with an aggressive biopathological profile. 114
Ruolo dei marcatori biologici negli stadi iniziali dei NSCLC tattati con resezione chirurgica radicale. Congresso Nazionale SICO 112
Attivazione in situ delle metalloproteinasi da parte del sistema fibrinolitico come meccanismo patogenetico della rottura della placca aterosclerotica. 112
INSL4 as prognostic marker for proliferation and invasiveness in non-small-cell lung cancer 111
Fine needle aspiration cytology of thyroid nodules: conventional smears vs thin layer technique 110
Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors. 110
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer 110
MYC and Human Telomerase Gene (TERC) Copy Number Gain in Early-stage Non-small Cell Lung Cancer 110
An additional case of breast tumor resembling the tall cell variant of papillary thyroid carcinoma. 109
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy 108
Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients. 107
A population survival model for breast cancer. 106
Could thymomectomy be a reasonable option for non-myasthenic thymoma patients? 105
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations. 105
Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer 105
A combined approach for thyroid fine needle aspiration: liquid based cytology, cell block and immunohistochemical methods with the implementation of the Cellient™ automated cell block system 103
Carcinoma della mammella pT1a: studio clinico-patologico 103
Mitotic index matter: how to improve the assessment of mitosis in order to better classify G2 breast cancer and luminal A category 103
Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients 101
SIGNIFICATO PROGNOSTICO DI ALCUNI PARAMETRI BIOPATOLOGICI IN 99 CASI DI CARCINOMA DEL POLMONE NON-MICROCITOMA STADIO I-II. Atti congresso congiunto: Società italiana Anatomia Patologica e Citologia Diagnostica (SIAPEC) e International Academy of Pathology (IAP). Pathologica Vol 91 100
ATTIVAZIONE IN SITU DELLE METALLOPROTEINASI DA PARTE DEL SISTEMA FIBRINOLITICO COME MECCANISMO PATOGENETICO DELLA ROTTURA DELLA PLACCA ATEROSCLEROTICA. 100
Tumori a cellule granulari (TCG): nuovi marcatori imunoistochimici. 99
Observational analysis on inflammatory reaction to talc pleurodesis: Small and large animal model series review 99
Osimertinib 98
Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib 98
A New Medium (HistoCold) for Surgical Specimens Preserving to Improve the Preanalytic Issues in Histopathological Samples Handling: Morphologic and Antigenic Analysis 97
Biological prognostic factors for early stage completely resected non-small cell lung cancer. 97
Future options for ALK-positive non-small cell lung cancer 96
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma 96
Modified gene expression of alveolar-capillar membrane, extracellular matrix and membrane proteins after induction chemotherapy for Non-Small Cell Lung Cancer 96
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study 96
Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy 96
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients 96
Detection of HER-/neu (c-erbB-2). Overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hybridization. 95
Tumore stromale gastrointestinale (GIST) in diverticolo di Meckel: descrizione di due casi 95
High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free servival in resected non-small-cell lung cancer patients. 95
Carcinomi mammari "triple negative": studio dei fattori prognostici e predittivi. 94
Espressione dei recettori HER nei carcinomi non a piccole cellule del polmone 94
Pleurodesis with Thulium Cyber Laser versus talc poudrage: a comparative experimental study 94
Detection of HER-2/neu (c-erbB-2) overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hibridization. 93
Immunohistochemical analisis of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in papillary thyroid carcinoma (PYC): a marker of lymph node metastasis. 93
Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC). 92
Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition 92
Targeting the KRAS variant for treatment of non-small cell lung cancer: Potential therapeutic applications 92
Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer 92
Current Challenges for IDO2 as Target in Cancer Immunotherapy 92
Toll-Like Receptor 4 and 8 are Overexpressed in Lung Biopsies of Human Non-small Cell Lung Carcinoma. 91
Carcinoma della mammella pT1a: studio clinico-patologico 90
Intrascrotal lipoblastoma: a case report and review of the literature. 90
Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter? 90
Clinical Outcome With Platinum-Based Chemotherapy in Patients With Advanced Nonsquamous EGFR Wild-Type Non-Small-Cell Lung Cancer Segregated According to KRAS Mutation Status. 90
Potential prognostic role of Indoleamine 2,3-dioxygenase 2 in human non-small cell lung cancer: an immunohistochemical study. 89
Breast cancer in young women: clinicopathological features and biological specificity. 89
High coexpression of both insulin-like growth factor receptor 1 (igfr-1) and epidermal growth factor receptor (egfr) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients 89
Biopathologic Profile of breast cancer in core biopsy: is it always a valid method? 89
KRAS mutation and DNA repair and synthesis genes in non-small-cell lung cancer 89
The clinical relevance of Bcl-2, Rb, p53 overexpression in advanced non small cell lung cancer. 88
A unique simultaneous occurrence of paratracheal granular cell tumor and papillary thyroid carcinoma. 88
PD-L1 quantification across tumor types using the reverse phase protein microarray: Implications for precision medicine 88
Espressione delle proteine osteogenetiche nel carcinoma prostatico: correlazioni anatomo-cliniche e significato prognostico 87
Il ruolo dell’ecografia nella definizione delle dimensioni delle neoplasie renali. Studio di confronto tra ecografia, TC e diametri anatomo-patologici 87
Evaluation of electrospun bioresorbable scaffolds for tissue-engineered urinary bladder augmentation. 87
Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro. 86
Totale 11.238
Categoria #
all - tutte 80.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021192 0 0 0 0 0 0 0 0 0 0 0 192
2021/20221.583 37 287 30 91 30 22 20 463 48 91 182 282
2022/20232.968 219 540 37 275 257 291 12 136 1.066 9 101 25
2023/20241.229 82 117 56 15 10 28 317 48 140 42 181 193
2024/20252.872 74 303 158 89 383 114 91 255 534 169 438 264
2025/20266.322 491 442 323 802 818 526 983 323 649 718 185 62
Totale 18.633